On August 3, 2020 Aileron Therapeutics (NASDAQ:ALRN) reported that Manuel Aivado, M.D., Ph.D., President and Chief Executive Officer, will participate in two upcoming investor conferences this month (Press release, Aileron Therapeutics, AUG 3, 2020, View Source [SID1234565068]).
Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:
Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing
Schedule Your 30 min Free Demo!
Thursday, August 6, 2020
Event: William Blair Biotech Focus Conference 2020
Time: 12:00 pm ET
*Fireside chat
Thursday, August 13, 2020
Event: Canaccord Genuity 40th Annual Growth Conference
Time: 4:30 pm ET
*Company overview and business update presentation
Live webcasts of these events will be available under the Investors and Media section of Aileron’s website at View Source A replay of the webcasts will be archived on Aileron’s website for 30 days following the respective events.